Drug intelligence / Profile preview

click editor (CE2)

Development stage
Preclinical
Lead developer
Massachusetts General Hospital
Modality
CRISPR-Cas9 → CRISPR Systems → Programmable Nucleases → Gene Editing → Gene Therapies
Administration
Intrathecal
01

Overview

Click editor (CE2) is a second-generation genome editing technology designed for precise genome writing. It consists of an RNA-programmable nickase (such as a CRISPR-Cas enzyme), a DNA-dependent DNA polymerase (DDP), and an HUH endonuclease (HUHe) domain. The HUHe domain facilitates the covalent attachment and recruitment of a single-stranded nucleic acid template (click DNA or clkDNA) that encodes the desired genetic modification. CE2 represents an optimization over the first-generation click editor (CE1) through protein engineering of the HUHe domain and chemical/structural optimization of the clkDNA substrate, resulting in significantly higher editing efficiency and potency at lower doses. The technology is being developed by researchers at Massachusetts General Hospital and the Technical University of Munich for potential therapeutic applications in genetic diseases.

Other names
second-generation click editor
02

Targets

Genomic DNA at the guide-RNA–specified locusDNA

Beyond the preview

Go deeper on click editor (CE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on click editor (CE2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call